https://biologicortho.com/index.php/BiologicOrtho/issue/feedBiologic Orthopedics Journal2024-10-15T18:01:27+00:00Scott Bryantsbryant@dougmargroup.comOpen Journal Systems<p style="margin: 0px; line-height: 115%;"><span style="margin: 0px; line-height: 115%; font-family: 'Garamond',serif; font-size: 14pt;">The Biologic Orthopedics Journal is being launched as a new online resource of evidence-based research and analysis, along with thoughtful discussion and commentary related to approaches to orthopedic biologics, their use and their promotion. The Journal will provide free and open access to scholarly work, education and discussion to meet the needs of practitioners, health workers, researchers, scientists and policy makers. The journal will be managed by the Biologic Orthopedics Journal Association, which will be responsible for administering the process of article submissions, review, and publication along with the supporting complements, a website and digital platform to empower readers of the journal and connect them to critical resources.</span></p> <p style="margin: 0px; line-height: 115%;"><span style="margin: 0px; line-height: 115%; font-family: 'Garamond',serif; font-size: 14pt;"> </span></p> <p style="margin: 0px; line-height: 115%;"><span style="margin: 0px; line-height: 115%; font-family: 'Garamond',serif; font-size: 14pt;">The Journal articulates and disseminates new science and clinical research for advancing the scholarship and practice of regenerative medicine in the field of orthopedics and to provide evidence-based best practices.<span style="margin: 0px;"> </span>The journal also increases world-wide exposure to the innovations, experiences and perspectives of practitioners working in the field. Article submissions are encouraged from throughout the world, and be subject to peer review. As such, this journal serves as a reputable and authoritative resource to help influence clinical practice, research funding, policy, and operational decisions regarding biologics in orthopedics. </span></p>https://biologicortho.com/index.php/BiologicOrtho/article/view/62Frontiers in Safety and Efficacy: Introduction2024-03-14T17:13:57+00:00Stephen J. Romansjrmd1@gmail.comScott Rodeorodeos@hss.eduWilliam D Murrelldoctormurrell@gmail.com<p><span data-contrast="auto">There are increasing numbers of people suffering with osteoarthritis and other musculoskeletal disorders. Current treatments for these conditions have significant side effects and comorbidities. Surgery in some cases may be inappropriate or ineffective. The use of regenerative medicine in the form of orthobiologics has been growing. The purpose of these treatments is to treat pain and to possibly enhance the healing of tissue pathology by augmenting the body’s inherent healing capabilities. Orthobiologic products commonly used include platelet rich plasma, adipose and bone marrow derived cellular products and birth tissue products. This review of the current medical literature has been prepared to provide evidence-based information to patients, clinicians, researchers, and regulatory and payer organizations with regard to the safety, efficacy, and cost effectiveness of orthobiologic treatments. </span><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-ccp-props="{"201341983":0,"335559739":160,"335559740":259}"> </span></p>2024-10-15T00:00:00+00:00Copyright (c) 2024 Stephen J. Roman, Scott Rodeo, William D Murrell